Clinical trial · Interventional
Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE
Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation Associated With Postoperative Transhepatic Arterial Chemoembolization--a Prospective Randomized Clinical Trial
NCT00730860CI-TRIAL-00026670unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A RCT was conducted to elucidate whether the treatment outcome of HCC could be improved by RFA associated with postoperative TACE.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer of Liver | Malignant Liver Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| radiofrequency ablation associated with TACE | Procedure | — | UNRESOLVED |
| radiofrequency ablation only | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- RFA+TACE
- description
- treatment of hepatocellular carcinoma by radiofrequency ablation associated with postoperative transhepatic arterial chemoembolization
- interventionNames
- Procedure: radiofrequency ablation associated with TACE
- type
- ACTIVE_COMPARATOR
- label
- RFA only
- description
- treatment of hepatocellular carcinoma by radiofrequency ablation only
- interventionNames
- Procedure: radiofrequency ablation only
Primary outcomes (1)
- measure
- disease free survival
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * patients with hepatocellular,confirmed by pathological examination * patients with a live function test showed Child A or B * Indocyanine green test showed less than 30％ after 15min,and the patients showed a tolerance of RFA and TACE * Tumor stage is early period(according to Milan Standard),that is,the diameter of single node should be less than 5cm；the node of tumor should be less than 3 and the diameter less than 3cm. * without metastasis in lymphnode or other organs * written consent inform assigned Exclusion Criteria: * preoperative examination showed malignant thrombosis in the first class branch of portal vein or hepatic vein or vena cava * metastatic cancer of liver * patients with a poor tolerance of RFA and TACE * patients received other therapies.
References
Publications (0)
Data not yet available
No reference posted for this study.